date:Nov 07, 2012
s profiled in the report include 3M Company, BioControl Systems, Inc., bioMrieux SA, Biolog, Inc., Celsis International Ltd., Charm Sciences, Inc., DuPont Qualicon, Inc., FOSS A/S, Eurofins GeneScan Europe AG, Genetic ID NA, Inc., Neogen Corp., R-Biopharm AG, SDIX, and Thermo Fisher Scientific, Inc.